What is HPV?
HPV (Human Papillomavirus) is a group of more than 50 viruses. It is one of the most common sexually transmitted infections throughout the world. HPV can infect both male and female skin and mucous membranes.
While most infections heal independently without causing any health problems, certain high-risk types of HPV can lead to the growth of conditions such as cervical cancer. HPV is primarily transmitted sexually but can also be transmitted through skin-to-skin contact. HPV Vaccine is an effective strategy for preventing HPV-related diseases such as cervical cancer.
What Is Cervical Cancer?
Cervical cancer is a cancer type that develops in the cervix, which links the uterus to the vagina. The infection of certain high-risk strains of the Human Papillomavirus (HPV) is the primary cause. Cervical cancer typically advances slowly, beginning with pre-cancerous alterations in the cervix's cells, known as cervical dysplasia. If left untreated, these aberrant cells can progress to aggressive cervical cancer. Cervical cancer symptoms include irregular vaginal bleeding, pain during sexual intercourse, pelvic pain and vaginal discharge.
Why Get a Cervical Cancer Vaccine?
Getting the cervical cancer vaccine is highly recommended for several important reasons. First and foremost, the vaccine protects against the most common high-risk types of Human Papillomavirus (HPV) that can lead to cervical cancer. Individuals can significantly reduce their risk of this potentially life-threatening disease by receiving the vaccine.
The cervical cancer vaccine is most effective when administered before becoming sexually active or exposed to HPV. This is because HPV is primarily transmitted through sexual contact, and the vaccine works by stimulating the immune system to build antibodies that can neutralize the virus. Therefore, getting vaccinated early, typically during adolescence, can provide the most significant benefit in terms of long-term protection.
It is important to note that the cervical vaccine does not protect against all types of HPV or all cases of cervical cancer. However, it provides significant protection against the most common high-risk types responsible for most cervical cancer cases. By reducing the risk of HPV infection, the vaccine also indirectly helps prevent other HPV-related cancers, such as vaginal, vulvar, anal, and oropharyngeal cancers.
In addition to preventing cervical cancer, the vaccine can also help reduce the burden of cervical abnormalities and related procedures. HPV infections can cause cervical dysplasia, abnormal cell changes in the cervix. These changes often require further diagnostic procedures and treatments, including biopsies and surgeries. By preventing HPV infections, the vaccine can help reduce the incidence of these potentially invasive and uncomfortable procedures.
Who Is Suitable For The Vaccine?
The cervical cancer vaccination is usually given to children aged 9 to 14. Vaccination at this age is advantageous since it occurs before most people become sexually active or are exposed to the Human Papillomavirus (HPV). Individuals can acquire protection against HPV before potential exposure by early vaccination.
However, the vaccine can still be provided to girls up to 26 and boys up to 21 who have never had the vaccine. To identify the ideal timing for immunization based on particular circumstances and health recommendations, speak to your doctor.
Are There Any Side Effects?
Like any vaccine, the cervical cancer vaccine can have side effects. Common vaccine side effects include redness or pain at the injection site, headache, and mild fever. Serious side effects are rare but can include allergic reactions.
